Cevimeline hydrochloride hemihydrate ((-)-SNI-2011), a novel muscarinic receptor agonist, is being explored as a potential treatment for xerostomia in Sjogrens syndrome, exhibiting an IC50 value indicative of its affinity for mAChR. This compounds pharma
Molecular Weight:
244.78
Formula:
C10H19ClNO1.5S
Target:
ALK
* VAT and and shipping costs not included. Errors and price changes excepted
